Accueil › Cancer du poumon non à petites cellules › Maryland › Germantown
Essais cliniques pour Cancer du poumon non à petites cellules à Germantown, MD
17 études pour Cancer du poumon non à petites cellules recherchent des participants dans et autour de Germantown (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Recrutement en coursPhase 1/2
- Virgnia Cancer Specialists /ID# 269633, Leesburg · à 16 mi
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Recrutement en coursPhase 3
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · à 4 mi
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Recrutement en coursPhase 3
- Maryland Oncology Hematology (MOH) ( Site 8102), Rockville · à 9 mi
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Recrutement en coursPhase 3
- Maryland Oncology Hematology P.A., Germantown
- Maryland Oncology Hematology PA, Rockville · à 9 mi
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Recrutement en coursPhase 3
- Research Site, Frederick · à 18 mi
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- Maryland Oncology Hematology, P.A., Germantown
- Maryland Oncology Hematology, P.A., Rockville · à 9 mi
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- James M Stockman Cancer Institute, Frederick · à 18 mi
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Recrutement en coursPhase 3
- Research Site, Leesburg · à 16 mi
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Recrutement en coursPhase 2/3
- Frederick Health Hospital- James M Stockman Cancer Institute, Frederick · à 18 mi
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Recrutement en coursPhase 2/3
- Local Institution - 007-814-C, Leesburg · à 16 mi
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Recrutement en coursPhase 3
- Inova Loudoun Hospital, Leesburg · à 16 mi
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Recrutement en coursPhase 1/2
- USOR Maryland Oncology Hematology, Rockville · à 9 mi
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Recrutement en coursÉtude observationnelle
- Frederick Health Hospital, Frederick · à 18 mi
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · à 4 mi
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2/3
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · à 4 mi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · à 4 mi
GEMINI-NSCLC: NSCLC Biomarker Study
Recrutement en coursÉtude observationnelle
- Frederick Health Regional System, Frederick · à 18 mi
Essais pour Cancer du poumon non à petites cellules dans d'autres villes
- Houston, TX145 études
- New York City, NY121 études
- Arlington, VA104 études
- Nashville, TN97 études
- Boston, MA90 études
- Los Angeles, CA87 études
- St. Louis, MO73 études
- Chicago, IL61 études
- Baltimore, MD60 études
- San Antonio, TX59 études
- Columbus, OH57 études
- Washington, DC55 études
Autres études à Germantown
- Schizophrénie11 études
- Cancer du sein10 études
- Cancer du poumon9 études
- Cancer (tous types)7 études
- Dépression7 études
- Obésité7 études
- Diabète de type 27 études
- Maladie cardiovasculaire6 études
- Cancer de la vessie6 études
- Surpoids5 études
- Trouble dépressif majeur5 études
- Hypertension artérielle4 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.